Quantification of Melanoma mRNA Markers in Sentinel Nodes: Pre-Clinical Evaluation of a Single-Step Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay
- 31 August 2004
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 6 (3) , 253-259
- https://doi.org/10.1016/s1525-1578(10)60518-1
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Sentinel lymph nodes in malignant melanomaCancer, 2004
- Prognostic Significance of Reverse Transcriptase-Polymerase Chain Reaction?Negative Sentinel Nodes in Malignant MelanomaAnnals of Surgical Oncology, 2003
- Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thicknessBritish Journal of Dermatology, 2001
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2000
- Histopathological workup of sentinel lymph nodes: how much is enough?Journal of Clinical Pathology, 1999
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Management of the regional lymph nodes in patients with cutaneous malignant melanomaWorld Journal of Surgery, 1992
- Nucleotide Sequence of the Putative Human Tyrosinase Pseudogene.The Tohoku Journal of Experimental Medicine, 1991
- Tyrosinase Protein Is Expressed Also in Some Neural Crest Derived Cells Which Are Not MelanocytesPigment Cell Research, 1988